trial · primary record
Baricitinib 4 milligram Oral Tablet
Lichen Planus, Oral
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2026-09-09 |
| Primary endpoint | Change in Oral Disease Severity Scale (ODSS) Scores |
| Registry ID | NCT06158113 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:44.771Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06158113
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.